Generic drugmaker Mylan said it will buy a unit of Strides Arcolab for $1.6 billion to expand its presence in the fast-growing injectable drugs market.
The post US drug maker Mylan buys Strides Arcolab unit for $1.6 bn appeared first on Firstpost.
Generic drugmaker Mylan said it will buy a unit of Strides Arcolab for $1.6 billion to expand its presence in the fast-growing injectable drugs market.
The post US drug maker Mylan buys Strides Arcolab unit for $1.6 bn appeared first on Firstpost.